featured
Diagnosis of Pseudoprogression Following Lomustine–Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Diagnosis of Pseudoprogression Following Lomustine-Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET PET
Clin. Cancer Res 2021 May 04;[EPub Ahead of Print], JM Werner, J Weller, G Ceccon, C Schaub, C Tscherpel, P Lohmann, EK Bauer, N Schäfer, G Stoffels, C Baues, E Celik, S Marnitz, C Kabbasch, GH Gielen, GR Fink, KJ Langen, U Herrlinger, N GalldiksFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.